Antioxidants in the treatment of hypertension

International Journal of Angiology

Volumn 14, Issue 2, 2005, Pages 60-73

  Vasdev, Sudesh ^a   Gill, Vicki ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; ASCORBIC ACID; CALCIUM CHANNEL; CAPTOPRIL; CYSTEINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLUTATHIONE; METHYLGLYOXAL; PYRIDOXAMINE; PYRIDOXINE; THIOCTIC ACID; THIOL; UBIDECARENONE;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DIET SUPPLEMENTATION; ENDOTHELIUM; ESSENTIAL HYPERTENSION; GASTROINTESTINAL SYMPTOM; GLUCOSE METABOLISM; GLYCATION; HEART DISEASE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FAILURE; LIFESTYLE; NONHUMAN; NUTRIENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; RISK FACTOR; VASCULAR RESISTANCE; VITAMIN SUPPLEMENTATION;

EID: 31844449066     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00547-005-2033-y     Document Type: Review

References (173)

1. Puska P, Mendis S, Porter D (2003) Chronic disease - key risk factors include high cholesterol, high blood pressure, low fruit and vegetable intake. In: World Health Organization fact sheet: Global strategy on diet, physical activity and health. Geneva: WHO, pp. 1-2.
2. Grant WB (1998) Reassessing the role of sugar in the etiology of heart disease. J Orthomol Med 13:95-104.
3. Vasdev S, Gill V, Longerich L, et al. (2004) Role of methylglyoxal in essential hypertension In: Pharmacotherapy of Heart Failure. Gupta SK, et al. (eds). New Delhi: Anamaya Publishers, pp 72-88.
4. Gonzalez-Albarran O, Ruilope LM, Villa E, et al. (1998) Salt sensitivity: Concept and pathogenesis. Diabetes Res Clin Pract 39:S15-S26.
5. Vasdev S, Gill V, Longerich L, et al. (2003) Salt-induced hypertension in WKY rats: Prevention by α-lipoic acid supplementation. Mol Cell Biochem 254:319-326.
6. Kumar KV, Das UN (1993) Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 19:59-66.
7. Wen Y, Killalea S, McGettigan P, et al. (1996) Lipid peroxidation and antioxidant vitamins C and E in hypertensive patients. Irish J Med Sci 165:210-212.
8. Salonen JT, Salonen R, Ihanainen M, et al. (1988) Blood pressure, dietary fat, and antioxidants. Am J Clin Nutr 48:1226-1232.
9. Moran JP, Cohen L, Greene JM, et al. (1993) Plasma ascorbic acid concentrations relate inversely to blood pressure hi human subjects. Am J Clin Nutr 57:213-217.
10. Ness AR, Chee D, Elliott P (1997) Vitamin C and blood pressure - an overview. J Hum Hypertens 11:343-350.
11. Bates CJ, Walmsley CM, Prentice AM, et al. (1998) Does vitamin C reduce blood pressure? Results of a large study of people aged 65 or older. J Hypertens 16:925-932.
12. Appel LJ, Moore TJ, Obarzanek E, et al. (2001) A clinical trial of the effects of dietary patterns on blood pressure. N Eng J Med 336(16):1117-1124.
13. Sacks FM, Svetkey LP, Vollmer WM, et al. (2001) Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet. N Eng J Med 344(1):3-10.
14. Martin DW, Mayes PA, Rodwell VW (1983) Harper's Review of Biochemistry, 19th ed. Los Altos, CA: Lange Medical Publications, pp 22, 101-105, 120, 183-184, 187-188, 597-599.
15. Ferrannini E, Buzzigoli G, Bonadonna R, et al. (1987) Insulin resistance in essential hypertension. N Eng J Med 313:350-357.
16. Flack JM, Sowers JR (1991) Epidemiologic and clinical aspects of insulin resistance. Am J Med 91:1A-11A.
17. Midaoui AEL, Elimadi A, Wu L (2003) Lipoic acid prevents hypertension, hyperglycemia and the increase in heart mitochondrial superoxide production. Am J Hypertens 16:173-179.
18. Shelmet JJ, Reichard GA, Skutches CL, et al. (1988) Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance. J Clin Invest 81:1137-1145.
19. Reaven GM (1991) Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med Suppl 2A:7S-12S.
20. Ogihara T, Asano T, Ando K, et al. (2002) High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 40:83-89.
21. Alexander MC, Lomanto M, Nasrin N, et al. (1988) Insulin stimulates glyceraldehyde 3-phosphate dehydrogenase gene expression through CIS-acting DNA sequences. Proc Natl Acad Sci 85:5092-50967
22. Thornalley PJ (1993) The glyoxalase system in health and disease. Mol Aspects Med 14:287-371.
23. Vander Jagt DL, Hunsaker LA (2003) Methylglyoxal metabolism and diabetic complications: Roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem Biol Interact 143-144:341-351.
24. Beisswenger PJ, Howell SK, Smith K, et al. (2003) Glyceraldehyde-3- phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 1637:98-106.
25. Morgan PE, Dean RT, Davies MJ (2002) Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch Biochem Biophys 403:259-269.
26. Chang KC, Paek KS, Kim HJ (2002) Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol 61:1184-1191.
27. Thornalley PJ, Battah S, Ahmed N, et al. (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375:581-592.
28. Schauenstein E, Esterbauer H, Zollner H (1977) Aldehydes in biological systems In: Aldehydes in biological systems, their natural occurrence and biological activities. Lagnado (ed). London: Pion Limited, pp 1-7.
29. Thorpe SR, Baynes JW (2003) Maillard reaction products in tissue proteins: New products and new perspectives. Amino Acids 25:275-281.
30. Nagaraja RH, Sarkar P, Mally A, et al. (2002) Effect of pyridoxamine on chemical modification of protein by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch Biochem Biophys 402:110-119.
31. Frye EB, Degenhardt TP, Thorpe SR (1998) Role of maillard reaction in aging of tissue proteins. J Biol Chem 273:18714-18719.
32. Odani H, Shinzato T, Usami J, et al. (1998) Imidazolium cross-links derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia. FEBS. Lett 427:381-385.
33. Ahmed N, Argirov OG, Minhas HS, et al. (2002) Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nε(1-carboxyethyl)lysine-modified albumin. Biochem J 364:1-14.
34. Karachalias N, Babaei-Jadidi R, Ahmed N, et al. (2003) Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rat. Biochem Soc Trans 31:1423-1425.
35. Alt N, Carson JA, Alderson NL, et al. (2004) Chemical modification of muscle protein in diabetes. Arch Biochem Biophys 425:200-206.
36. Schmidt AM, Yan SD, Yan SF, et al. (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108:949-955.
37. Wautier MP, Chappey O, Corda S, et al. (2001) Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280:E685-E694.
38. 2+ release from sarcoplasmic reticulum via an oxidation reaction. J Biol Chem 264:21725-21736.
39. Aoki K, Kawaguchi Y, Sato K, et al. (1982) Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats. J Cardiovasc Pharmacol 4:S298-S302.
40. Robinson BF (1984) Altered calcium handling as a cause of primary hypertension. J Hypertens 2:453-460.
41. Vasdev S, Ford CA, Parai S, et al. (2000) Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens 18:567-573.
42. Vasdev S, Ford CA, Parai S, et al. (2000) Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr Metab Cardiovasc Dis 10:339-346.
43. Stadtman TC (1990) Selenium biochemistry. Ann Rev Biochem 59:111-127.
44. Park YS, Koh YH, Takahashi M, et al. (2003) Identification of the binding site of methylglyoxal on glutathione peroxidase: Methylglyoxal inhibits glutathione peroxidase activity via binding to glutathione binding sites Arg 184 and 185. Free Rad Res 37:205-211.
45. Wu L, Juurlink BHJ (2002) Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 39:809-814.
46. Degenhardt TP, Thorpe SR, Baynes JW (1998) Chemical modification of proteins by methylglyoxal. Cell Mol Biol 44:1139-1145.
47. Brandwein HJ, Lewicki JA, Murad F (1981) Reversible inactivation of guanylate cyclase by mixed disulfide formation. J Biol Chem 256:2958-2962.
48. Mizutani K, Ikeda K, Tsuda K, et al. (2002) Inhibitor for advanced glycation end product formation attenuates hypertension and oxidative stress in genetic hypertensive rats. J Hypertens 20:1607-1614.
49. Patel JM, Block ER (1995) Sulfhydryl-disulfide modulation and the role of disulfide oxidoreductases in regulation of the catalytic activity of nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 13:352-359.
50. Vasdev S, Ford CA, Longerich I, et al. (1998) Aldehyde-induced hypertension in rats: Prevention by N-acetylcysteine. Artery 23:10-36.
51. Beisswenger PJ, Howell SK, O'Dell RM, et al. (2001) Alpha-dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabet Care 24:726-732.
52. Metz TO, Alderson NL, Thorpe SR, et al. (2003) Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch Biochem Biophys 419:41-49.
53. Stitt A, Gardiner TA, Anderson NL, et al. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826-2832.
54. Cooke CLM, Brockelsby JC, Baker PN (2003) The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Preg 22:173-184.
55. Scherrer U, Sartori C (2000) Defective nitric oxide synthesis: A link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrin 142:315-323.
56. Kahn NN, Acharya K, Bhattacharya S, et al. (2000) Nitric oxide: The "second messenger" of insulin. IUBMB Life 49:441-450.
57. Sechi LA, Griffin CA, Giacchetti G, et al. (1996) Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension 27:955-961.
58. Ibarra M, Meneses A, Ransanz V, et al. (1995) Changes in endothelium-dependent vascular responses associated with spontaneous hypertension and age in rats. Arch Med Res 26:S177-S183.
59. Kamata K, Yamashita K (1999) Insulin resistance and impaired endothelium-dependent renal vasodilatation in fructose-fed hypertensive rats. Res Commun Mol Pathol Pharmacol 103:195-210.
60. Manning RD, Hu L, Tan DY, et al. (2001) Role of abnormal nitric oxide systems in salt-sensitive hypertension. Am J Hypertens 14:68S-73S.
61. Touyz RM, Schiffrin EL (2004) Reactive oxygen species in vascular biology: Implications in hypertension. Histochem Cell Biol 122:339-352.
62. Sagar S, Kallo U, Kaul N, et al. (1992) Oxygen free radicals in essential hypertension. Mol Cell Biochem 111:103-108.
63. Koska J, Syrova D, Blazicek P, et al. (1999) Malodialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension. J Hypertens 17:529-535.
64. 2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups. Biochim Biophys Acta 1052:333-339.
65. Oba T, Yamaguchi M (1990) Sulfhydryls on frog skeletal muscle membrane participate in contraction. Am J Physiol 259:C709-C714.
66. Dargel R (1992) Lipid - peroxidation a common pathogenetic mechanism? Exp Toxic Pathol 44:169-181.
67. Tabatabaie T, Floyd RA (1994) Susceptibility of glutathione peroxidase and glutathione reductase to oxidative damage and the protective effect of spin trapping agents. Arch Biochem Biophys 314:112-119.
68. Benedetti A, Comporti M, Esterbauer H (1980) Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 620:281-296.
69. Taddei S, Virdis A, Ghiadoni L, et al. (2000) Endothelial dysfunction and hypertension. J Nephrol 13:205-210.
70. Ma X-L, Gao F, Nelson AH, et al. (2001) Oxidative inactivation of nitric oxide and endothelial dysfunction I stroke-prone spontaneously hypertensive rats. J Pharmacol Exp Ther 298:879-885.
71. Zalba G, Beaumont FJ, San Jose G, et al. (2001) Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction. Nephrol Dial Transplant 16:S2-S5.
72. Cahuana GM, Tejedo JR, Jimenez J (2003) Involvement of advanced lipooxidation end producet (ALEs) and protein oxidation in the apoptotic actions of nitric oxide in insulin secreting RINm5F cells. Biochem Pharmacol 66:1963-1971.
73. Janero DR, Burghardt B (1989) Cardiac membrane vitamin E and malondialdehyde levels in heart muscle of normotensive and spontaneously- hypertensive rats. Lipids 24:33-38.
74. Ito H, Torii M, Suzuki T (1992) A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium. Comp Biochem Physiol 103B:37-40.
75. Singal PK, Beamish RE, Dhalla NS (1983) Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 161:391-401.
76. Uchida K, Stadtman ER (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 268 (9):6388-6393.
77. Packer L, Witt EH, Tritschler HJ (1995) Alpha-lipoic acid as a biological antioxidant. Free Rad Biol Med 19:227-250.
78. Packer L, Tritschler HJ, Wessel K (1997) Neuroprotection by metabolic antioxidant alpha-lipoic acid. Free Rad Biol Med 22:359-378.
79. Vasdev S, Mian T, Ford CA, et al. (1996) Role of endogenous aldehydes in spontaneously hypertensive and disulfiram-induced hypertension rats. Nutr Metab Cardiovasc Dis 6:1-11.
80. Vasdev S, Ford CA, Longerich L, et al. (1998) Role of aldehydes in fructose induced hypertension. Mol Cell Biochem 181:1-9.
81. Cabassi A, Dumont EC, Girouard H, et al. (2001) Effects of chronic N-acetyl cysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens 19:1233-1244.
82. Girouard H, Chulak C, Le Jossec M, et al. (2003) Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rat. J Hypertens 21:179-188.
83. Girouard H, Chulak C, Wu L, et al. (2003) N-Acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats. Am J Hypertens 16:577-584.
84. Girouard H, Denault C, Chulak C, et al. (2004) Treatment by N-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. Am J Hypertens 17:947-954.
85. Song D, Hutchings S, Pang CCY (2005) Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats. Eur J Pharmacol 508:205-210.
86. Barrios V, Calderon A, Navarro-Cid J, et al. (2002) N-Acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients. Blood Press 11:235-239.
87. Fulghesu AM, Ciampelli M, Muzj G, et al. (2002) N-Acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril 77:1128-1135.
88. Santini MT, Cametti C, Indovina PL, et al. (1998) Menadione induces changes in the membrane electrical properties associated with downregulation of insulin receptors in human erythrocytes. Exp Hematol 26:466-471.
89. Ammon HP, Hehl KH, Enz G, et al. (1986) Cysteine analogues potentiate glucose-induced insulin release in vitro. Diabetes 35:1390-1396.
90. Uysal M, Bulur H, Sener D, et al. (1986) Lipid peroxidation patients with essential hyperetension. Int J Clin Pharmacol Ther Toxicol 24:474-476.
91. Ferrari R, Ceconi C, Curello S, et al. (1991) Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med 91:S95-S105.
92. Ramasamy S, Drummond GR, Ahn J, et al. (1999) Modulation of expression of endothelial nitric oxide synthase by nordihydroguaiaretic acid, a phenolic antioxidant in cultured endothelial cells. Am Soc Pharmacol Exp Ther 56:116-123.
93. Pieper GM, Siebeneich W (1998) Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 32:101-105.
94. Finkelstein JD, Chalmers FT (1970) Pyridoxine effects on cystathionine synthase in rat liver. J Nutr 100:467-469.
95. Takeuchi F, Izuta S, Tsubouchi R, et al. (1991) Glutathione levels and related enzyme activities in vitamin B-6 deficient rats fed a high methioinine and low cystine diet. J Nutr 121:1366-1373.
96. Smolin LA, Benevenga NJ (1982) Accumulation of homocyst(e)ine in vitamin B-6 deficiency: A model for the study of cystathionine β-synthase deficiency. J Nutr 112:1264-1272.
97. 6 on the systolic blood pressure of rats in various animal models of hypertension. J Hypertens 14:355-363.
98. Vasdev S, Ford CA, Parai S, et al. (1999) Dietary vitamin B6 supplementation attenuates hypertension in spontaneously hypertensive rats. Mol Cell Biochem 200:155-162.
99. Vasdev S, Longerich L, Gill V (2004) Prevention of fructose-induced hypertension by dietary vitamins. Clin Biochem 37:1-9.
100. Aybak M, Sermet A, Ayyildiz MO, et al. (1995) Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittel forschum 45:1271-1273.
101. Spellacy WN, Buhi WC, Birk SA (1977) Vitamin B6 treatment of gestational diabetes mellitus. Am J Obstet Gynecol 127:599-602.
102. Kannan K, Jain SK (2004) Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes. Free Radic Biol Med 36:423-428.
103. Miner SE, Cole DE, Evrovki JM, et al. (2001) Pyridoxine improves endothelial function in cardiac transplant recipients. J Heart Lung Transplant 20:964-969.
104. Emmert DH, Kirchner JT (1999) The role of vitamin E in the prevention of heart disease. Arch Fam Med 8:537-542.
105. Atarashi K, Ishiyama A, Takagi M, et al. (1997) Vitamin E ameliorates the renal injury Dahl salt-sensitive rats. Am J Hypertens 10:116S-119S.
106. Newaz MA, Newal NNA, Rohaizan CH, et al. (1999) α-Tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. Am J Hypertens 12:839-844.
107. Pezeshk A, Dalhouse AD (2000) Vitamin E, membrane fluidity, and blood pressure in hypertensive and normotensive rats. Life Sci 67:1881-1889.
108. Noguchi T, Ikeda K, Sasaki Y, et al. (2001) Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens Res 24:735-742.
109. Vasdev S, Gill V, Parai S, Longerich L, et al. (2002) Dietary vitamin E supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem 238:111-117.
110. Vasdev S, Gill V, Parai S, et al. (2002) Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats. Mol Cell Biochem 241:107-14.
111. Vasdev S, Gill V, Parai S, et al. (2005) Dietary vitamin E supplementation attenuates hypertension in Dahl salt-sensitive rats. J Cardiovasc Pharmacol Thera 10:103-111.
112. Iino K, Abe K, Kariya S, et al. (1977) A controlled, double-blind study of dl-alpha-tocopheryl nicotinate (Juvela-Nicotinate®) for treatment of symptoms in hypertension and cerebral arteriosclerosis. J Heart J 18:277-286.
113. Boshtam M, Rafiei M, Sadeghi K (2002) Vitamin E can reduce blood pressure in mild hypertensives. Int J Vit Nutr Res 75:309-314.
114. Jessup JV, Horne C, Yarandi H, et al. (2003) The effects of endurance exercise and vitamin E on oxidative stress in the elderly. Biol Res Nurs 5:47-55.
115. Bendich A, Gabriel E, Machlin LJ (1983) Differences in vitamin E levels in tissues of the spontaneously hypertensive and Wistar-Kyoto rats (41560). Proc Soc Exp Biol Med 172:297-300.
116. Akyol D, Mungan T, Görkemli H, et al. (2000) Maternal levels of vitamin E in normal and preeclamptic pregnancy. Arch Gynecol Obstet 263:151-155.
117. Paolisso G, D'Amore A, Giugliano D, et al. (1993) Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 57:650-656.
118. Barbagallo M, Dominguez LJ, Tagliamonte MR, et al. (1999) Effect of vitamin E and glutathione on glucose metabolism. Role of magnesium. Hypertension 34:1002-1006.
119. Costagliola C, Libondi T, Menzione M, et al. (1985) Vitamin E and red blood cell glutathione. Metabolism 34:712-714.
120. Paolisso G, Giugliano D, Pizza G, et al. (1992) Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care 15:1-7.
121. Kitiyakara C, Wilcox CS (1998) Antioxidants for hypertension. Curr Opin Nephrol Hypertens 7:531-538.
122. Yoshioka M, Aoyama K, Matsushita T (1985) Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats (SH rats). Int J Vit Nutr Res 55:301-307.
123. Ettarh RR, Odigie IP, Adigun SA (2002) Vitamin C lowers blood pressure and alters vascular responsiveness in salt-induced hypertension. Can J Pharmacol 80:1199-1202.
124. Vasdev S, Ford CA, Parai S, et al. (2001) Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem 218:97-103.
125. Duffy SJ, Gokce N, Holbrook M, et al. (1999) Treatment of hypertension with ascorbic acid. Lancet 354:2048-2049.
126. Hajjar IM, George V, Sasse EA, et al. (2002) A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther 9:289-293.
127. Cierello A, Guigliano D, Quatrara A (1991) Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci 81:739-742.
128. Ghosh SK, Ekpo EB, Shah IU, et al. (1994) A double-blind, placebo-controlled parallel trial-of vitamin C treatment in elderly patients with hypertension. Gerontology 40:268-272.
129. Fotherby MD, Williams JC, Forster LA, et al. (2000) Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 18:411-415.
130. Ward NC, Hodgson JM, Croft KD, et al. (2005) The combination of vitamin C and grape seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 23:427-434.
131. Lovat LB, Lu Y, Palmer AJ, et al. (1993) Double-blind trial of vitamin C in elderly hypertensives. J Hum Hypertens 7:403-405.
132. Meister A (1992) Commentary on the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol 44:1905-1915.
133. Paolisso G, Balbi V, Volpe C, et al. (1995) Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 14:387-392.
134. Meister A (1994) Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 269:9397-9400.
135. Johnston CS, Meyer CG, Srilakshmi JC (1993) Vitamin C elevates red blood cell glutathione in healthy adults. Am J Clin Nutr 58:103-105.
136. Varma SD, Bauer SA, Richards RD (1987) Hexose monophosphate shunt in rat lens: Stimulation by vitamin C. Invest Ohthamol Vis Sci 28:1164-1169.
137. Paolisso G, D'Amore A, Balbi V, et al. (1994) Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetes. Am J Physiol 266(2 pt 1):E261-E268.
138. May JM, Qu Z-C (2004) Nitric oxide-induced oxidant stress in endothelial cells: amelioration by ascorbic acid. Arch Biochem Biophys 429:106-113.
139. Taddei S, Virdis A, Ghiadoni L, et al. (1998) Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97:2222-2229.
140. Solzback U, Hornig B, Jeserich M, et al. (1997) Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 96:1513-1519.
141. Visioli F, Smith A, Shang W, et al. (2002) Lipoic acid and vitamin C potentiate nitric oxide synthesis in human aortic endothelial cells independently of cellular glutathione status. Redox Rep 7:223-227.
142. Frei B, England L, Ames BN (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 86:6377-6381.
143. Chakraborty S, Nandi A, Mukhopadhyay M, et al. (1994) Ascorbate protects guinea pig tissues against lipid peroxidation. Free Radic Biol Med 16:417-426.
144. Frei B, Kirn MC, Ames BN (1990) Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA 87:4879-4883.
145. Singh RB, Niaz MA, Rastogi SS, et al. (1999) Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens 13:203-208.
146. 10 on experimental hypertension in rats and dogs. J Pharmacol Exp Ther 189:149-156.
147. 10 on structural alterations in the renal membrane of stroke-prone spontaneously hypertensive rats. Biochem Med Metab Biol 45:216-226.
148. Danysz A, Oledzka K, Bukowska-Killiszek M (1994) Influence of coenzyme Q-10 on the hypotensive effects of enalapril and nitrendipine in spontaneously hypertensive rats. Pol J Pharmacol 46:457-461.
149. 10 and essential hypertension. Res Commun Chem Pathol Pharmacol 11:273-288.
150. 10 to patients with essential hypertension. Res Commun Chem Pathol Pharmacol 14:721-727.
151. 10 on essential hypertension. A double blind controlled study. In: Biomedical Aspects of Coenzyme Q. Folkers K, Yamamura Y (eds). Elsevier Publishers, Vol. 5, pp. 337-343.
152. 10. Res Common Chem Pathol Pharmacol 31:129-139.
153. 10 on essential arterial hypertension. Curr Ther Res 47:841-845.
154. 10 in essential arterial hypertension. Curr Thersp Res 51:668-672.
155. 10 in essential arterial hypertension. Mol Aspects Med 15:S257-S263.
156. 10. Mol Aspects Med 15:S265-S272.
157. 10 in isolated systolic hypertension. South Med J 94:1112-1117.
158. Stacker R, Dowry VW, Frei B (1991) Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 88:1646-1650.
159. 10 improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Daibetologia 45:420-426.
160. Thirunavukkarasu V, Nandhini ATA, Anuradha CV (2003) Lipoic acid restores antioxidant system in tissues of hyperinsulinaemic rats. Ind J Med Res 118:134-140.
161. Vasdev S, Gill V, Parai S, et al. (2005) Dietary lipoic acid supplementation attenuates hypertension in Dahl Salt Sensitive rats. Mol Cell Biochem XX:XXX-XXX.
162. Thirunavukkarasu V, Nandhini ATA, Anuradha CV (2004) Lipoic acid attenuates hypertension and improves insulin sensitivity kallikrein activity and nitrite levels in high fructose-fed rats. J Comp Physiol B 174:587-592.
163. Morcos M, Borcea V, Isermann B, et al. (2001) Effect of α-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract 52:175-183.
164. Konrad T, Vicini P, Kusterer K, et al. (1999) α-Lipoic acid treatment decreases serum lactate and pyruvate concentrations, and improves glucose effectiveness in lean, and obese patients with type 2 diabetes. Diabetes Care 22:280-287.
165. Jacob S, Henriksen EJ, Tritschler HJ, et al. (1996) Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabetes 104:284-288.
166. Jacob S, Henriksen EJ, Schiemann AI, et al. (1995) Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittel forschung 45:872-874.
167. Henriksen EJ, Jacob S, Streeper RS, et al. (1997) Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese zucker rats. Life Sci 61:805-812.
168. Thirunavukkarasu V, Anuradha CV (2004) Influence of α-lipoic acid on lipid peroxidation and antioxidant defence system in blood of insulin-resistant rats. Diabetes Obes Metab 6:200-207.
169. Koçak G, Aktan F, Canbolat O, et al. (2000) Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab 13:308-318.
170. Takaoka M, Kobayashi Y, Yuba M (2001) Effects of α-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur J Parmacol 424:121-129.
171. Heitzer T, Finckh B, Albers S, et al. (2001) Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 31:53-61.
172. Kagan VE, Serbinova EA, Forte T, et al. (1992) Recycling of vitamin E in human low density lipoproteins. J Lipid Res 33:385-397.
173. Lonn E, Bosch J, Yusuf S, et al. (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer. A randomized controlled trial. JAMA 293:1338-1347.